(Publication) PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia.

Kothari J, Eyre T, Rismani A, Ediriwickrema K, Edwards D, Galani S, Wilson W, Lawrie A, Clifton-Hadley L, McCarthy H, Collins A, Lewis D, Ar [...]

(Publication) Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma

Sesques P, Kirkwood AA, Kwon M, Rejeski K, Jain MD, Di Blasi R, Brisou G, Gros FX, le Bras F, Bories P, Choquet S, Rubio MT, Iacoboni G, O'R [...]

(Publication) A Prospective Observational Cohort Study for Newly Diagnosed Osteosarcoma Patients in the UK: ICONIC Study Initial Results

Alexa Childs, Craig Gerrand, Bernadette Brennan, Robin Young, Kenneth S. Rankin, Michael Parry, Jonathan Stevenson, Adrienne M. Flanagan, Ra [...]

(Publication) The IMRiS Trial: A Phase 2 Study of Intensity Modulated Radiation Therapy in Extremity Soft Tissue Sarcoma

Beatrice Seddon MD, PhD, Franel Le Grange MD, Rita Simões MSc, Chris Stacey BSc, MSc, Shumona Shelly BSc, MSc, Sharon Forsyth BSc, Laura Whi [...]